It was originally reported to be physiologically expressed by prostate cells [3, 4].A Strong upregulation in prostate cancer cells, which was further described, led to the development of PSMA-based imaging technologies for the detection of metastatic disease in advanced prostate cancer. The gene discussed is FOLH1; the disease is prostate carcinoma.